Careland Lidocaine Plus Menthol Pain Relieving Gel Patches

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Careland Lidocaine Plus Menthol Pain Relieving Gel Patches
Generic name
LIDOCAINE, MENTHOL
Manufacturer
Planet (Anhui) Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
8b607c03-a98f-445a-a69e-7625a76ac44b
SPL ID
570a89d2-0522-179e-e063-6294a90a1897
Version
1
Effective date
2026-07-20
Source export date
2026-10-12
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:29:26
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only Do not use • more than 1 patch at a time • with a heating pad • on wounds or damaged skin • if you are allergic to any ingredients of this product When using this product • Use only as directed • Do not bandage tightly • Avoid contact with the eyes, mucous membranes or rashes Stop use and ask a doctor if • symptoms persist for more than 7 days • conditions worsen • symptoms clear up and occur again within a few days • localized skin reactions, such as rash, itching, redness, pain, swelling and blistering develop If pregnant or breast feeding, ask a health professional before use Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.